Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/VENI stock hub

CSE/VENI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/VENIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/VENI

In the news

Latest news · CSE/VENI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/VENI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

134

Groups with data

Currency

USD

Showing 134 of 134 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD -704,636
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA92260V1031
Last refreshed	2026-05-10
Market cap	CAD 1.1M
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	6720
Symbol	cse/VENI
Website	https://vencanna.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-224.9%
EV Earnings	0.28x
EV/FCF	0.82x
FCF yield	-77.1%
P/B ratio	1.24x
P/S ratio	0.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-82.34%
EBITDA Margin	-102.41%
Gross margin	-39.7%
Gross Profit	CAD -1.1M
Net Income	CAD -2.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-100.3%
Profit Margin	-91.14%
ROCE	-142.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.02%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	-40.07x
Revenue Growth Q	-64.01x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 3.8M
Cash	CAD 44,463
Current Assets	CAD 849,310
Current Liabilities	CAD 2.2M
Debt	CAD 646,989
Debt Equity	CAD 0.72
Debt FCF	CAD -0.75
Equity	CAD 900,738
Interest Coverage	-6.38
Liabilities	CAD 2.9M
Long Term Assets	CAD 2.9M
Long Term Liabilities	CAD 666,503
Net Cash	CAD -602,525
Net Cash By Market Cap	CAD -54.12
Net Debt Equity	CAD 0.67
Tangible Book Value	CAD 3.1M
Tangible Book Value Per Share	CAD 0.01
WACC	22.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.38
Net Working Capital	CAD -1.3M
Quick ratio	0.16
Working Capital	CAD -1.4M
Working Capital Turnover	CAD -8.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50%
50-day SMA	0.01
All Time High	0.03
All Time High Change	-83.33%
All Time High Date	2024-05-28
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2024-09-05
ATR	0
Beta	1.03
Beta1y	-0.68
Beta2y	0.51
High	0.01
High52	0.02
High52 Date	2025-05-20
High52ch	-66.67%
Low	0.01
Low52	0.01
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-32.43%
RSI	44.94
RSI Monthly	23.1
RSI Weekly	33.65
Sharpe ratio	2.74x
Sortino ratio	5.9
Total Return	-4.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.3M
Operating margin	-82.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	169,653,472%
Net Borrowing	-234,022.6
Shares Insiders	23.8%
Shares Out	222,644,952
Shares Qo Q	0%
Shares Yo Y	4.87%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -858,345
Average Volume	92,021.55x
Bv Per Share	0.01
CAPEX	CAD -216,992
Ch1y	-50
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	-555,556.8
Dollar Volume	125
EBIT	CAD -2.3M
EBITDA	CAD -2.8M
EPS	CAD -0.01
F Score	1
FCF	CAD -858,345
FCF EV Yield	121.81x
FCF Per Share	CAD -0
Financing CF	-232,201
Fiscal Year End	April
Income Tax	CAD 90,879
Investing CF	-220,653
Is Primary Listing	1
Last Earnings Date	2024-12-27
Last Report Date	2026-01-31
Ma20	0.01
Ma20ch	-28.57%
Net CF	-1,104,705
Open	0.01
Ppne	2,574,887.9
Price Date	2026-05-08
Ptbv Ratio	0.36
Relative Volume	0.27x
Revenue	2,746,940x
Tax By Revenue	3.31x
Volume	25,000
Z Score	-12.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/VENI pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/VENI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/VENI?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+23.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.9%

Negative means the company is buying back shares.

Technical

CSE/VENI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.9

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

1.03

Moves roughly with the market

Sharpe ratio

2.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/VENI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/VENI stock rating?

cse/VENI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/VENI analysis?

The full report lives at /stocks/cse/VENI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/VENI?

The latest report frames cse/VENI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/VENI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.